MHRA grants conditional marketing authorisation1 for COVID-19 treatment Xevudy (sotrovimab) Read more
Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001 Read more
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy Read more
FDA Accepts for Priority Review the Supplemental Biologics License Application for Merck’s VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and Children Read more
Premas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron Variant of Concern Read more
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle Read more